How Pear Therapeutics is Creating Digital Therapeutics to Treat Substance Use Disorders
May 15, 2016
52:16
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Pear Therapeutics CEO Corey McCann, MD, PhD delves into the potential digital therapeutics have in helping people who abuse drugs and alcohol. The company’s product pipeline includes potential treatment for schizophrenia, combat-PTSD, generalized anxiety disorder, insomnia and traumatic brain injury.